Alkermes
Corporate Social Responsibility (CSR), Sustainability and Cause News & Media
Alkermes
Flexible Media Releases
Apr 12, 2021 11:40 AM ET


Apr 8, 2021 1:35 PM ET


Apr 6, 2021 1:05 PM ET


Pages


Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases. The company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction, multiple sclerosis and oncology. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes’ website at www.alkermes.com.